Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ('ugly') locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

Autor: van den Berg, K., Schaap, D. P., Voogt, E. L. K., Buffart, T. E., Verheul, H. M. W., de Groot, J. W. B., Verhoef, C., Melenhorst, J., Roodhart, J. M. L., de Wilt, J. H. W., van Westreenen, H. L., Aalbers, A. G. J., van 't Veer, M., Marijnen, C. A. M., Vincent, J., Simkens, L. H. J., Peters, N. A. J. B., Berbée, M., Werter, I. M., Snaebjornsson, P., Peulen, H. M. U., van Lijnschoten, I. G., Roef, M. J., Nieuwenhuijzen, G. A. P., Bloemen, J. G., Willems, J. M. W. E., Creemers, G. J. M., Nederend, J., Rutten, H. J. T., Burger, J. W. A.

Publikováno v: BMC Cancer, 22(1):957. BioMed Central Ltd
BMC Cancer, 22(1):957. BioMed Central
BMC Cancer, 22
BMC Cancer, 22(1):957. BioMed Central Ltd.
BMC Cancer, 22, 1
van den Berg, K, Schaap, D P, Voogt, E L K, Buffart, T E, Verheul, H M W, de Groot, J W B, Verhoef, C, Melenhorst, J, Roodhart, J M L, de Wilt, J H W, van Westreenen, H L, Aalbers, A G J, van 't Veer, M, Marijnen, C A M, Vincent, J, Simkens, L H J, Peters, N A J B, Berbée, M, Werter, I M, Snaebjornsson, P, Peulen, H M U, van Lijnschoten, I G, Roef, M J, Nieuwenhuijzen, G A P, Bloemen, J G, Willems, J M W E, Creemers, G J M, Nederend, J, Rutten, H J T & Burger, J W A 2022, ' Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer : study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT) ', BMC Cancer, vol. 22, no. 1, 957, pp. 957 . https://doi.org/10.1186/s12885-022-09947-w

Background The presence of mesorectal fascia (MRF) invasion, grade 4 extramural venous invasion (EMVI), tumour deposits (TD) or extensive or bilateral extramesorectal (lateral) lymph nodes (LLN) on MRI has been suggested to identify patients with ind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e5e66763b1aab2bcbd20c945d69797
https://doi.org/10.1186/s12885-022-09947-w

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The ORCHESTRA trial; A phase III trial of adding tumour debulking to systemic therapy versus systemic therapy alone in multi-organ metastatic colorectal cancer (mCRC)

Autor: Bakkerus, L., Gootjes, E. C., van der Stok, E. P., Buffart, T. E., Zonderhuis, B. M., Tuynman, J. B., Meijerink, M. P., van de Ven, P. M., Haasbeek, C. J., Ten Tije, A. J., de Groot, J. W., Radema, S. A., Hendriks, M. P., Helgason, H. H., van Meerten, E., Nuyttens, J. J., Grunhagen, D. J., Verhoef, C., Verheul, H. M. W.

Publikováno v: Bakkerus, L, Gootjes, E C, van der Stok, E P, Buffart, T E, Zonderhuis, B M, Tuynman, J B, Meijerink, M P, van de Ven, P M, Haasbeek, C J, Ten Tije, A J, de Groot, J W, Radema, S A, Hendriks, M P, Helgason, H H, van Meerten, E, Nuyttens, J J, Grunhagen, D J, Verhoef, C & Verheul, H M W 2019, ' The ORCHESTRA trial; A phase III trial of adding tumour debulking to systemic therapy versus systemic therapy alone in multi-organ metastatic colorectal cancer (mCRC) ', Annals of Oncology, vol. 30 .
Annals of Oncology, 30. Oxford University Press

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::760ce3ae1903af7e26280c50536ee95c
https://research.vumc.nl/en/publications/1a4d255b-627b-4811-a494-bdac5a8117a3

Hepatic Artery Infusion Chemotherapy Combined with Modern Systemic Therapy in Chemotherapy-Naive Patients with Unresectable Colorectal Liver Metastases

Autor: Verheij, F.S., Kuhlmann, K.F.D., Silliman, D., Krul, M.F., Buffart, T., Kingham, T.P., Kemeny, N.E., Cercek, A., Jarnagin, W.R., Kok, N.F.M., D'Angelica, M.I.

Publikováno v: In HPB 2022 24 Supplement 1:S93-S93